/Align%20Technology%2C%20Inc_%20magnified-by%20Pavel%20Kapysh%20via%20Shutterstock.jpg)
With a market cap of $12.7 billion, Tempe, Arizona-based Align Technology, Inc. (ALGN) designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States and internationally.
Companies worth $10 billion or more are generally described as "large-cap stocks." ALGN falls squarely into this category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the medical instruments & supplies industry. ALGN offers CAD/CAM digital services used in dentistry, orthodontics, and dental records storage through its two operating segments, Clear Aligner and CAD/CAM Services.
Shares of ALGN touched their 52-week high of $263.24 on Jul. 18, 2024, and have fallen 31.6% from that peak. They have grown 9.4% over the past three months, outperforming the Health Care Select Sector SPDR Fund’s (XLV) 9.3% fall over the same time frame.
Shares of the company have declined 25.7% over the past 52 weeks, compared to XLV’s 8.7% fall over the same time frame. Moreover, ALGN stock is down 13.7% on a YTD basis, underperforming XLV’s 3.2% fall.
ALGN shares have been trading below their 200-day moving average for the past year and mostly above their 50-day moving average since late April.
On Apr. 30, ALGN shares declined 2.5% following the release of its Q1 results. The company’s revenue came in at $979.3 million, beating Wall Street forecasts of $972.8 million. Its adjusted EPS of $1.52 surpassed Wall Street expectations marginally. ALGN expects revenue in the range of $1.05 billion to $1.07 billion for Q2.
Its peer, Solventum Corporation (SOLV), has surged 10% in 2025 and 36.2% over the past year, outperforming the stock.
Among the 13 analysts covering the ALGN stock, the consensus rating is a “Moderate Buy.” Its mean price target of $234.25 suggests a 30.1% upside potential from current price levels.
